When Boston began to take COVID-19 pandemic precautions last year, the Boston Lyric Opera had just opened a production of Bellini’s Norma. Artistic director Esther Nelson turned to a longtime friend of the organization to help them determine whether the season could go on.
Celiac Disease Program
Charles River Plaza
165 Cambridge Street, 9th Floor
Boston, MA 02114
Hours: Monday–Friday, 8:00 am–5:00 pm
Services also available at:
Mass General North Shore Center for Outpatient Care
102-104 Endicott Street
Danvers, MA 01923
Explore This Program
A Multidisciplinary Approach to Care
The prevalence of celiac disease in the U.S. has quadrupled over the past 50 years. The Celiac Disease Program at Mass General brings together an expert team of providers who work with patients with celiac disease to co-create health.
This multi-disciplinary care team is tailored to each patient’s unique condition. Our providers include:
- GI pathologists
- GI radiologists
- Food allergy specialists
We offer the full range of endoscopic diagnostic procedures critical for obtaining a tissue diagnosis and differentiating celiac disease from other disorders such as inflammatory bowel disease (Crohn's disease and ulcerative colitis), microscopic colitis (lymphocytic and collagenous), eosinophilic and autoimmune enteritis, and irritable bowel syndrome (IBS).
Patient Education and Support
Patient education and support are important components of our mission. We are committed to helping patients understand their disease, assess their treatment options, participate in their treatment decisions and feel in control of their disease. Our physicians are experienced in fine-tuning medical therapies and helping patients obtain relief from persistent, difficult-to-manage symptoms.
To help educate the community about how our diet, lifestyle and environment can affect GI health, our doctors participate in community events throughout the year.
Advancing an Understanding of Celiac Disease through Ongoing Research
The Celiac Disease Program at Mass General is a comprehensive program dedicated to the diagnosis and treatment of patients with celiac disease and all gluten-mediated disorders. The gastroenterology department at Massachusetts General Hospital is consistently ranked among the nation's top programs, with Magnet award-winning nurses providing patients with compassionate, timely care. Magnet designation represents the highest honor available for nursing excellence and is achieved by fewer than 7% of hospitals in the United States. Our multidisciplinary team of providers has been recognized both nationally and internationally for groundbreaking research and outstanding patient care.
We believe that each patient can significantly improve our knowledge of celiac disease and contribute toward understanding the factors that influence the development of this disease and factors that determine response to treatments. All of the physicians involved in the Celiac Disease Program actively participate in research programs aimed at understanding the underlying cause of celiac disease, with the goal of developing more effective treatment approaches.
Dr. Ramnik Xavier directs a research program that focuses on understanding the genetic basis of celiac disease based on genome-wide association studies. Dr. Xavier's research group actively collaborates with the lab of Dr. Cisca Wijmenga, a world leader in the genetics of celiac disease. In addition, Dr. Xavier works closely with Dr. Bana Jabri, a renowned immunologist who is working with Dr. Xavier to develop systems biology approaches to understanding the fundamental mechanisms underlying celiac disease.
Dr. John Garber III conducts a research program in intestinal epithelial biology with the goal of understanding factors that regulate the intestinal barrier both in the healthy state as well as in the setting of diseases such as celiac and inflammatory bowel disease. The integrity of the intestinal barrier is determined primarily by intercellular junctions, which also represent one of the primary pathways by which gluten gains access to the immune system. Despite the critical importance of intestinal junctions as a determinant of epithelial function, relatively little is known about the fundamental mechanisms that control the stability and responsiveness of junctions. Our lab is actively investigating the cellular constituents and mechanisms that function in intestinal junction assembly and turnover.
- Feb | 23 | 2021
Genetic counselors from the Mass General Preventive Genomics Clinic share the advantages and limitations of direct-to-consumer and consumer-initiated genetic tests.
- Feb | 18 | 2021
Christopher Learn, MD, of the Corrigan Minehan Heart Center and Department of Medicine, reviews the opportunities and challenges of adolescents and young adults transitioning to adult care providers.
- Press Release
- Jan | 21 | 2021
Study finds that daily aspirin use does not reduce risk of colorectal cancer among adults who begin taking it after age 70.
- Jan | 15 | 2021
Megan Lockwood, MD, a Rheumatology Unit fellow at Mass General, provides an overview of osteoporosis and reviews screening and treatment options.
- Staff Story
- Jan | 14 | 2021
The Department of Medicine’s inaugural gingerbread house competition featured Dr. Fauci and many references to Mass General, COVID-19 and the current vaccination effort ... all created with delicious treats.